Health Archive » February, 2024

Health - February, 2024

477 articles

• 9th Circ. Sends COVID-19 Coverage Row Back To Tribal Court
• UnitedHealth Unit Says Blackcat Group Behind Cyberattack
• SF City Atty Seeks To Exit US News 'Best Hospitals' Probe Suit
• Tenet To Sell 2 Calif. Hospitals To Adventist For $550M
• Judge Wary Of Wading Into AG's 'Abortion Pill Reversal' Probe
• BlossomHill Therapeutics Closes $100M Series B
• Insurance Co. Settles Mass. Worker's Long COVID Suit
• Colo. Panel Revives Wound Center's Damages Suit
• Harvard Faces Appeal Of Ruling Over Alleged Body Part Sales
• Sandoz To Pay $265M To Resolve Claims In Price-Fixing MDL
• Faulty Expert Report Can't Support Stomach Surgery Suit
• Epstein Becker Guides Conn. Hospital, NY Nonprofit Merger
• 9th Circ. Says Fight Over COVID-19 Misinformation Law Moot
• Auto Co. Says $50M Policy Endorsement Covers COVID Loss
• Law Firm Recruited Objectors To Tank Vax Deal, Class Says
• Chancery Rejects Leadership Bid Over Lack Of Del. Counsel
• Abortion Coverage Remains Steady Post Dobbs, Survey Says
• Medtronic Says 3 Years Of Tax Returns Under IRS Audit
• Bankrupt Endo To Pay $465M To Resolve Opioid Claims
• 7 Common Myths About Lateral Partner Moves
• 7th Circ. Revives Health System Worker's FMLA Suit For Trial
• Ga. Panel Brings Doctor In, Publix Out In Drug Allergy Case
• Trans Teens Tell High Court To Pass On Idaho's Stay Request
• Retainer Signature Dispute Ends In Nixing Of NJ Billing Suit
• NC Hospital, Nurses Get OK For Settlement Of Bias Suit
• Attys Get $750K Fee Award In $6M Med Tech Co. Deal
• Senate GOP Blocks Bill To Federally Protect IVF
• Cravath Steers Viatris' $350M Collab With Swiss Co.
• Fish & Richardson Adds Ex-Jenner & Block Life Sciences Duo
• When Physician Retirement Arrangements May Be Legal
• 4 Firms Plan To Co-Lead Suboxone Dental Decay MDL
• Judge Says Ermi Counterclaims In Qui Tam Case Can Stand
• Cheering In The NFL Makes Me A Better Lawyer
• AdaptHealth, Ex-CEO Cut $51M Deal To End Investor Fight
• WilmerHale Adds Ex-Medtronic Legal Leader To Its DC Office
• Dexcom Rival Fights Its Bid To Tweak Glucose Monitor Patent
• Novant In-House Attys Want Access To Confidential FTC Info
• NuVasive Can Pierce Co. To Collect From Ex-Rep, Judge Says
• Nurse Wants Staff Co. Wage Suit Paused For 11th Circ. Appeal
• Air Force Contractor Strikes Deal In EEOC Disability Bias Suit
• Biden Moves To Halt Flow Of American Data To China, Others
• NY Hospital Says PE-Owned Anesthesia Co. Monopolizes Care
• Mich. AG Backs Abortion Challenge, But Urges Narrow Block
• Hospital Groups Allege Opioid Crisis Damaged Their Finances
• Veradigm To Acquire ScienceIO, Face Potential Nasdaq Delisting
• DC Circ. Rejects Hospital's NLRB 'Successor Bar' Challenge
• Monsanto Wants Further 11th Circ. Roundup Suit Review
• Keeping Up With Class Actions: Data Breach Litigation In Flux
• Senate Dems Plan IVF Bill Vote After Ala. High Court Ruling
• Anesthesia Group Settles Colo. AG's Monopoly Claims
• Survey Finds Just 4 in 10 Healthcare Orgs. Review AI Guidance
• Args In APA Case Amplify Justices' Focus On Agency Power
• Ascension Unit Will Pay $2.6M To End Time Clock BIPA Suit
• Careismatic Creditors Lash Out At DIP Proposal
• Arnold & Porter Transactions Vet Joins Foley & Lardner
• Fox Rothschild Taps Sarasota-Area Firm Attys For New Office
• Conn. Agency Asks Judge To Rethink Tuition Refund Pause
• Hospital Denies Nurses OT For Work During Breaks, Suit Says
• NIST Widens Cybersecurity Framework To Cover All Industries
• NC Health Data Breach Class Deal Gets Preliminary OK
• Medical Device Companies Settle Ga. Wrongful Death Suit
• NC Hospital's Weak Data Security Led To Breach, Suit Says
• 'Rebel Alliance' Seeks Court Rescue In Opioid Discovery Clash
• Teva Tells 1st Circ. Feds Must Clear High Bar In FCA Case
• Stimwave Prosecutors Accused Of Brady Violation Mid-Trial
• ESG Around The World: Gulf Cooperation Council
• NJ Town Justified Hospital-Only Zone, Appeals Panel Says
• Texas Nursing Home Must Face Suit Over Resident's Uri Death
• Ropes & Gray-Led THL Taking Agiliti Private In $2.5B Deal
• Catching Up With Delaware's Chancery Court
• Navigating ACA Reporting Nuances As Deadlines Loom
• Sheppard Mullin Adds 2nd Healthcare Partner This Month
• Justices Say Tribes Can Argue Separately In Healthcare Row
• Paul Hastings Adds FDA Practice Chair From King & Spalding
• Seattle Hospital Gets Facebook Browser Tracking Suit Tossed
• State Farm Alleges Health Co. Violated Deal To Drop 366 Suits
• Chamber's Report Bemoans Biden's March-In Idea For Drug IP
• DOD Watchdog Flags Increased Emphasis On Contract Fraud
• Fla. Doctor Says T-Mobile Let Hacker Steal Her SIM Card
• Idaho Blasts 'Abortion Mandate' In High Court State Ban Fight
• Healthcare AI Startup Abridge Raises $150M
• 8th Circ. Says Nursing Home Fraudster Owes Supplier $7.6M
• US Trustee Objects To Rite Aid Disclosure Statement
• Inside The PTAB's Seagen Cancer Drug Patent Decision
• Walgreens Investors Near Deal In Suit Over Opioid Epidemic
• Feds Ask Judge To Keep Steward Qui Tam Lawsuit Intact
• A Cautionary Tale On Hospital-Physician Alignment Structures
• VA Nixes Trans Vets' Request For Gender-Affirming Surgery
• Trade Group Tells NC Justices COVID-19 Losses Not Covered
• Christian Clinic Says Trans Surgery Suit Bolsters Mich. Fears
• 6 Pointers For Attys To Build Trust, Credibility On Social Media
• Eye Care Tech Co. Gets Go-Ahead For April Sale In Ch. 11
• Healthcare Group Of The Year: Simpson Thacher
• Holland & Knight Product Liability Ace Rejoins Reed Smith
• Family Dollar Accused Of Knowingly Selling Unsafe Drugs
• CVS Says Redbox Won't Remove Kiosks Despite Expired Deal
• Wash. AG Seeks $1.2M In Damages For Debt Collector's Errors
• Justices Urged To Affirm Limits On Mifepristone Access
• Law Firm Sued For Using Photo Of Disgraced OB-GYN Online
• NYC Doc Charged Over $20M Lab-Fraud Kickback Scheme
• North Carolina Hospitals Can't Exit Monopoly Claims
• HHS' Civil Rights Office Reaches 2nd-Ever Ransomware Deal
• Conn. AG Defends $10M Remedy Bid Against Nursing School
• DOJ Reports $2.7B False Claims Act Haul In 2023
• Opioid Drug Co. Sued In Del. For Promotion-Tied Stock Drop
• Mass. Medical Regulator Seeks Pregnancy Center Records
• Total Vision's Antitrust Suit Against VSP Kept Largely Intact
• 'Baffled' Judge Tells Attys Flo Health Case Isn't 'World War III'
• Fired Exec Says Conn. Hospital Booted Her For Her Age
• HHS Warning to Congress: Health Data Breaches Surging
• 9th Circ. OKs NLRB's Dues Stance, But Judge Decries Shifts
• Biotech VC Firm ORI Capital Closes $260M Fund
• Texas Pharmacists Paid Doctors Kickbacks, Prosecutors Say
• Mich. Judge OKs $52M Deal For Mayo Foundation Subscribers
• 11th Circ. Backs Mayo Clinic Win In Race, Sex Bias Case
• Biden Admin's March-In Plan Would Hurt Medical Innovation
• 5 Lessons For SaaS Companies After Blackbaud Data Breach
• Why Biz Groups Disagree On Ending Chevron Deference
• Anapol Weiss Absorbs Injury Boutique Attys, Adds Partner
• Healthcare Biz Founder Seeks Legal Costs For Fraud Fight
• Fla. Whistleblower Suit Deal Averts Littler's Disqualification
• Hearst Lands Win Over Boston Videographer's Vax Claims
• ICE's Immunity Bars Bulk Of Virus Death Suit, For Now
• Healthcare Group Of The Year: Ropes & Gray
• Locke Lord Settles Failed Health Plan Malpractice Suit
• Deals Rumor Mill: Occidental, Kroger-Albertsons, BuzzFeed
• Esformes Gets Time Served In Plea Deal With Gov't
• Nurses Ignored Surgery Patient's Fatal Sepsis, Fla. Jury Hears
• Del. Suit Accuses Healthcare Data Co. Exec Of Insider Trading
• Texas Panel Unsure Hospital Should Escape $6M MedMal Suit
• Hospital Debt Collector To Pay $1M To End Wash. AG's Claims
• 39 AGs Call For Federal Pharmacy Benefit Manager Reform
• Judges Doubt Surgery Center Co. Can Undo Contract Loss
• FDA Let Pharma Co. 'Sidestep' Application Rules, Court Told
• Pa. High Court Returns Insurer's Status Question To 3rd Circ.
• Idaho Asks High Court For Stay In Gender Care Ban Dispute
• Doc Keeps Trial Win In Suit Over Patient's Medication List
• Morgue Manager's Wife Cops To Role In Body Part Sales
• Rite Aid Gets OK To End Former Queens Store Lease
• 'Loser Pays' Arbitration Pact Spurs Age Bias Case's Revival
• Oregon Law Would Compromise Management Service Orgs
• Actelion Cites FDA Safety Rules Against Tracleer Antitrust Suit
• Calif. Bill Would Let AG Audit Private Equity Healthcare Deals
• JPMorgan Got $400M Before Inovalon Sale, Del. Justices Hear
• A Post-Mortem Analysis Of Stroock's Demise
• Conn. Court Pauses Refund Plan For Ex-Nursing Students
• Juror Misconduct Warrants New Trial In Birth Injury Suit
• 3rd Circ. Kicks Data Privacy Suit Against Penn To State Court
• J&J Beats Suit Alleging Sunscreen Caused Ga. Woman's Cancer
• 3rd Circ. Lets J&J Appeal Class Cert. In Talc Concealment Suit
• Healthcare Practice Group Of The Year: McDermott
• Kratom Buyers Say Sellers Hid Opioid-Like Addiction Risks
• Liberal Justices Hint Chevron Deference Hanging By A Thread
• Groups, Scholars Back Tribes In High Court Healthcare Bid
• 2nd Circ. Won't Restore Allergan Investors' Breast Implant Suit
• Walgreens Defeats $200M Investor Suit Over Insulin Billing
• Jury Says LSD Didn't Cause Quadriplegia; Insurer To Pay $1M
• High Court Blocks Bid By 3 States To Join Abortion Drug Case
• US Trustee Wants Sorrento Ch. 11 Tossed Or Relocated
• High Court Won't Pick Up Medical Drivers' Class Status Row
• Ill. Cardiologist Keeps Trial Win In Med Mal Death Suit
• Ala. Justices Deem Frozen Embryos Children Under State Law
• Patent Atty Group Supports Vanda In High Court Patent Case
• Eateries' Virus Losses Not Covered, Insurer Tells NC Justices
• Biotech Co. SomaLogic, Former Exec Settle Fight Over Stock
• Biology AI Startup Bioptimus Raises $35M Seed Round
• Ga. Justices Clarify Official's Role In Hospital Expansion Law
• $71M Deal Proposed To End Premier Inc. Share Exchange Suit
• Cedars-Sinai Can't Escape Ex-Worker's Retirement Fee Suit
• Permanent Need Dooms Request For H-2B Home Health Aides
• Steward Health CEO Accused Of $45M Dividend Fraud
• Fed. Circ. Backs Microsoft's PTAB Win Over 3D Patents
• Justices Decline Malpractice Dispute Over $6M Settlement
• Insurers Say Pollution Exclusion Bars Cancer Suits Defense
• Healthcare Group Of The Year: Hogan Lovells
• Preparing For DOJ's Data Analytics Push In FCPA Cases
• 'Perfect Storm' Allows For Med Mal Suit Deadline Extension
• Pa. Contractor Says Ohio Cosmetic Centers Skipped $2M Bill
• Justices Won't Touch UBH Mental Health Coverage Case
• Judge Seeks Briefing On New Expert Proposed In Tylenol MDL
• 11th Circ. Upholds Insurer's Win In Worker's Health Bias Fight
• Athira Pharma Investors Win OK Of $10M Deal On Second Try
• ADA Does Not Protect Medical Pot Use, Vt. Court Says
• NC's Stein Supports Abortion Drug Manufacturer In W.Va. Case
• Family Of 23-Year-Old Who Died From Ulcer Gets $30M
• The Congressman Who Reps Cannabis Reform On Capitol Hill
• Va. Couple Sues CooperSurgical Over Destroyed Embryos
• Catching Up With Delaware's Chancery Court
• Lack Of Affidavit Gets NJ Med Mal Death Suit Tossed
• Reducing The Risk Of PFAS False Advertising Class Actions
• Fired Hospital Worker Can't Keep Fighting PTO Denial
• Insurer Seeks To Cancel $15M Policy Over 'Human Life Wager'
• Ape Farm Says Ga. Officials Monkeying With $300M Bond Deal
• Chromocell Hits Stock Markets Following $6.6M IPO
• Medtronic Urges 8th Circ. To Undo Transfer Pricing Ruling
• DC Circ. Sends Ambulance Co. Info Spat Back To NLRB
• Therapy Co.'s Policy Lie Bars Fraud Coverage, 4th Circ. Says
• Littler Hit With DQ Bid For Wielding Mistakenly Produced Doc
• Taxation With Representation: Paul Weiss, Kirkland
• Janssen FCA Claims Not Barred By Old Cases, Judge Says
• Telemedicine Exec Admits $110M Medicare Fraud Scheme
• UK Litigation Roundup: Here's What You Missed In London
• Greenberg Traurig Adds FDA Expert From Emord & Associates
• 3rd Circ. Says Rutgers Can Mandate COVID-19 Vaccines
• 'Body Sculpting' Device Co. Faces Investor Suit Over Pricing
• House Committee Blasts VA, Oracle For E-Record Failures
• DOJ Fights 'Outdated' Tenn. Law On HIV-Positive Sex Workers
• Citadel Securities, Others Beat Biotech Spoofing Suit, For Now
• HHS Targets Biz Group's Standing In Bid To End Medicare Suit
• Profs Say W.Va. Mifepristone Ban 'Out Of Step' With Regs
• HCA Says NC Hospital's Standard Of Care Hasn't Changed
• Invitae Can Use Cash Collateral For Speedy Ch. 11
• Michigan Wants 1 Panel For 3 Appeals Of LGBTQ Rights Laws
• Court Mulls If Claims Buyer Qualifies For Special Ch. 11 Trust
• Freenome Raises $254M For Early Cancer Detection Tests
• What Rescheduling Pot Would Mean For Criminal Justice Reform
• Wash. High Court Affirms Liberty Mutual's Bill Review System
• Ga. Judge Hits Medicare Kickback Con Artist With 30 Months
• Lincare To Pay $25.5M To Settle FCA, Anti-Kickback Litigation
• Aurinia Refocusing After Failed Effort To Find A Buyer
• USCIS Fee Increases May Have Unintended Consequences
• Med Monitoring Claims In Philips MDL Sent Back For Review
• Lawmakers Push PE Firm For Answers On Steward Health
• FTC's Khan Calls Healthcare 'Key' To Fight For Competition
• Petition Watch: Classes, Litigation Changes & Fraud Theories
• HR Antitrust Compliance Crucial Amid DOJ Scrutiny
• Lessons From Rare Post-Verdict Healthcare Fraud Acquittal
• Colo. Hospital Sued For Denying Gender Dysphoria Surgery
• Karuna Faces Investor Suit Over $14B Bristol Myers Buyout
• Mo. Hospital Faces Action Over Breach Of 500K Patients' Data
• Judge Keeps FCA Case Against Kaiser Permanente Alive
• FTC Seeks Info On 'Powerful Middlemen' Amid Drug Shortages
• NYC Sues Facebook, Social Media Cos. Over Teen Addiction
• Adagio Medical Goes Public In $128M SPAC Merger
• Software Co. Inks $4M Deal In Privacy Suit Over Breached Info
• Pharma Co. Humanigen Gets OK For Ch. 11 Sale
• Ohio Doc. Group Not Named Too Late In Neck Injury Suit
• Biotech Nabs $200M Via Private Placement, Starts CEO Search
• Fox News' Sorrento Report Takes Center Stage At 9th Circ.
• ChristianaCare Settlement Reveals FCA Pitfalls For Hospitals
• SmileDirectClub Trustee Wants To Cut Leases To Stop Losses
• Mich. Health Co. Settles Payroll Outage Dispute For $325K
• 2nd Circ. Nixes LGBTQ Groups' Suit Against HHS Grant Policy
• Dad Sues Hacked Chicago Children's Hospital Again
• Perkins Coie Keeps Malpractice Win Over Trustee's Standing
• Texas Ruling Clarifies That Bankruptcy Shields LLC Rights
• Coaching High School Wrestling Makes Me A Better Lawyer
• Dentists Can't Get Class Certification In SmileDirectClub Suit
• KKR Buys Stake In Health Tech Biz Cotiviti At $10.5B Valuation
• Genetic Testing Co. Invitae Files For Ch. 11 With $1.5B Debt
• Philly Judge Must Reconsider Venue For Tooth Implant Suit
• LabCorp Sued Over Sharing Sensitive Health Info With Google
• 6th Circ. Backs Drugmakers' Early Win In Diabetes Drug MDL
• Wash. Justice Worries Religious Rights Muscle Out Others
• Planned Parenthood Says Immunity Ignored In FCA Case
• CMS Must Rethink $4M Training Contract Award, GAO Rules
• Insurers Must Pay Pharma Co. Defense Costs In SEC Probe
• Biden Admin Drops Appeal Over Trump 'Conscience Rule'
• Billing Cos. Deny Claims By Health Facility In $7M Fraud Case
• Wash. Justices Doubtful HR Manager Can't Be Served
• FDA, Creditors Oppose Drugmaker Humanigen's Ch. 11 Sale
• Texas Appeals Court Grants Medical Coding Co.'s Atty Fee Bid
• Nava Health To Go Public Via $320M SPAC Merger
• Tribes Seek Split Arguments In High Court Healthcare Dispute
• Biden Administration Beats Big Pharma Texas Medicare Suit
• LSD Trip Didn't Cause Quadriplegia, Houston Jury Told
• Convicted NC Doctor Can't Get Recordings From Prosecutors
• Officer Says He Was Denied Work Due To Race, Med. Pot Use
• Cigna Patients Can't Get Class Cert. In Underpayment Suit
• Catching Up With Delaware's Chancery Court
• SG's Office Is Case Study To Help Close Legal Gender Gap
• The Latest Antitrust Areas For In-House Counsel To Watch
• Staffing Co. Sues NC Nursing Home Over Unpaid Invoices
• Mallinckrodt Guts IP Suit Amid Oxide Rival's New Drug App
• 6 Sentenced For $20M COVID Aid Fraud Scheme
• Fox Rothschild Beefs Up Government Contracts Team In DC
• Catholic Hospital's Religious Status Dooms Vaccine Bias Suit
• Breast Implant Maker Sientra Hits Ch. 11 With $82M In Debt
• DOL's Benefits Arm Reports $1.4B In Recoveries In 2023
• Meta Can't Trim Non-Facebook Users' Health Privacy Suit
• Investors Win Class Cert. Against Failed COVID Test Maker
• Assure Buys Danam Health To Form $150M Business
• Alys Pharmaceuticals Launches With $100M In Financing
• GAO Says Ambiguity Protest Too Late In HHS Comms Deal
• Judge Orders Arbitration In Fla. Doctor's New Contract Claim
• Pa. Judge Won't Certify Class In Juvenile Facility Abuse Suit
• Rite Aid Seeks To Extend Ch. 11 Exclusivity To Late April
• Ex-CEO Of Health Co. Found Guilty Of Fraud After $195M Loss
• NJ Lands $6.4M Deal Over 'Bogus' Medicare Billing Claims
• NC High Court Snapshot: Philip Morris Fights Tax Credit Limit
• Despite Risks, AI Is A Worthy Tool For Healthcare Industry
• Ex-NJ County Health Director Claims Ouster Due To Age, Politics
• Harvard Not Liable For Alleged Morgue Body Part Sales
• Cigna Patients Say Underpayment Claims Ripe For Class Cert.
• Trust Tells NC Biz Court To Oust Atrium From Inheritance
• Geico Says Medical Fraudsters Nabbed $1.1M In Auto Benefits
• Health Atty Rejoins Troutman Pepper After Solo Practice Stint
• Gilead Buying Liver Disease Drugmaker CymaBay For $4.3B
• Rise In Billing For Catheters May Signal $2B Medicare Fraud
• Conn. Judge Guts Healthcare Staffing Co. Partnership Suit
• Rite Aid Investors' Attys Get $58M As Walgreens Deal OK'd
• DEA Wrong To Block Psilocybin Therapy, 9th Circ. Told
• Pharma Co. Beats Investor Suit Over Licensing Agreement
• 3rd Circ. Won't Revive Fired Officer's Infertility Leave Bias Suit
• Fed. Circ. Backs Gov't Win In Fla. University's Patent Dispute
• HHS Sued Over $12M Bill After Lengthy Claim Review
• Healthcare Cybersecurity Bill Puts Focus On HHS Oversight
• Mental Health App Says Former Exec Can't Lead Rival
• Navigating New Regulations In Healthcare And Other M&A
• Healthcare-Focused SPAC Hits The Market After $160M IPO
• Pot Patients Say NM Insurance Case Triggers CAFA Exception
• FTC Clears AbbVie To Proceed With $10.1B ImmunoGen Buy
• Humanigen Creditors Say DIP Loan Ties Up Too Many Assets
• SF Atty Faces Misconduct Charges Over $1.33M In Trust Fees
• Goodwin-Led Gene Editing Firm Metagenomi Raises $94M IPO
• Kaufman Dolowich Adds Ex-Financial Services CLO In Fla.
• What To Know About 'Novel' Johnson & Johnson ERISA Suit
• 23andMe Led To Late Father And $28M Verdict, Woman Says
• Feds Seek Over 5 Years For NYC Atty In $18.8M Ponzi Scheme
• Eargo Investors Sue In Del. For Patient Square Merger Docs
• UK Litigation Roundup: Here's What You Missed In London
• Service Failure On Expert Reports Dooms Texas Med Mal Case
• $490M FCA Verdict Against Medical Distributor Cut In Half
• White House Patent Plan To Curb Drug Prices Draws Outcry
• BioNTech Puts $200M Into Collab With Cancer Biotech Autolus
• HHS Won't Invoke IP Rights To Lessen Xtandi Prices
• Biotech Co. Neurona Therapeutics Raises $120M
• Eyewear Buyers Want To Consolidate 6 EssilorLuxottica Suits
• FDA Settles Allegations Of Uneven Blood Treatment Standards
• Watchdog Faults VA For Failing To Vet Contract Personnel
• Providers Can't Appeal Medicaid Expulsion, NC Justices Told
• Mich. Counties Sue Drug Giants Over Insulin Prices
• Drugmaker Challenges W.Va. Abortion Ban In 4th Circ.
• Dentists In $13B Delta Dental Suit Want Class Status
• Ga. Judge Hits Medicare Fraud Duo With 37-Month Sentences
• New CMS Rule Will Change Nursing Facility Disclosures
• Broker Hit With Suit Over Data Breach Affecting 1.5 Million
• Skirting Anti-Kickback Causation Standard Amid Circuit Split
• Question On Wrongful Death Damages Sent To Ga. Justices
• What To Know About WDTX Standing Order For Patent Cases
• Doctor In NBA Fraud Case Can Ditch Atty Over Plea Squabble
• Conn. Doc Says Website Must Unmask Fake Online Reviewer
• Aurora Cannabis Buys No. 2 Australian Medical Pot Co.
• What New Calif. Strike Force Means For White Collar Crimes
• Seattle Hospital Owes $215K In Mold Suit, Jury Finds
• Philips Rival Seeks Interest After Treble Damages Award
• Paul Hastings, Covington Guide Kyverna's Upsized $319M IPO
• Morgan Lewis Adds Hawkins Parnell Toxic Tort Litigator In LA
• 2nd Circ. Skeptical Of Reviving Investors' Breast Implant Suit
• US Tells 9th Circ. Stem Cell Clinic Not Exempt From FDA Rules
• Med Mal Case Dropped Before Wash. Justices Decide Blame
• Life Sciences VC Scion Launches With $310M Fund
• Fla. Justices Hesitant To Limit Abortion Ballot Measure
• Wash. High Court Won't Review J&J Patient Privacy Ruling
• Surgical Robot Co. Sued Over Internal Burns, Death Of Patient
• Conn. Justices OK $35M Verdict, Punt On 'Wrongful Life'
• GOP Lawmakers, AG Spar Over NC Abortion Medication Limits
• Pfizer, Moderna Spar Over Trial Date In COVID Vaccine IP Case
• Acella's $46.5M Drug Recall Settlement Gets Initial Signoff
• NJ Panel Backs Retired Cops In Health Insurance Dispute
• Healthcare Collabs Can Alleviate Labor, Antitrust Challenges
• 4 Private Equity Firms Wrap Funds Totaling $1.45B
• Penn State Health To Pay $11.7M To US Over Improper Billing
• Mich. Abortion Clinics Sue Over Waiting Period, Counseling
• Ward & Smith Nabs $170K Fee In NC Trade Secrets Fight
• Investor Wants Fla. CBD Co.'s Atty DQ'd In Fraud Suit
• NC Panel Reverses Doctor's Malpractice Coverage Win
• Reimagining Law Firm Culture To Break The Cycle Of Burnout
• Apple Defeats Antitrust Suit By AliveCor Over Apple Watch
• HHS Signs $4.75M Pact With NYC Hospital Over Data Theft
• Seattle Hospital Must Pay Up For 'Huge' Negligence, Jury Told
• Calif. Lawmakers Pitch New Psychedelics Treatment Bill
• Staffing Firm To Exit Pa. Nurse's Wage Action
• 10th Circ. Affirms $4.7M Stryker Loss, But Tosses Fee Award
• Drugmaker Eyes Ch. 11 Pivot In Bid To Stave Off Liquidation
• Cano Health DIP Gets Initial OK Without $23M Lender Fees
• Judge Accepts DHA's Course-Correct For $65B Tricare Deal
• Judge Won't Toss All Claims In COVID Test Securities Action
• Appeals Court Upholds Insurers' COVID-19 Coverage Win
• JPML Consolidates Suboxone Dental Decay Suits In Ohio
• NC Virus Law Won't Free Surgeon From Med Mal Suit, Panel Says
• 'Surprise Billing' Law Can't Pin Insurer, Conn. Justices Told
• Medical Device Co. Accuses Ex-Sales Reps Of Stealing Clients
• Attys Seek $750K Fee In Del. For $6M Med Tech Co. Deal
• Expediting Psychedelics Approvals In The EU, UK, Australia
• Express Scripts Cites Low Bar To Keep AG Suit In Fed. Court
• McDermott-Led 3 Boomerang Nabs $375M For Debut Fund
• ESG Around The World: Brazil
• Gilead Ruling Signals That Innovating Can Lead To Liability
• AI Operating System Built For Healthcare Lands $70M
• Vagueness In Calif. Climate Law Makes Compliance Tricky
• Grant Compliance Takeaways From Ga. Tech's FCA Settlement
• Kirkland-Led Trinity Hunt Partners Raises $700M For 7th Fund
• Dispensary Says State Agency Delayed Shutdown Ruling
• Competing In Dressage Makes Me A Better Lawyer
• Freshfields Helps Novartis Buy German Pharma In €2.7B Deal
• Kochava Can't Shake FTC's Location Data Privacy Suit
• Psychedelics Bill Roundup: Mass. Proposal Enters Legislature
• Tennessee Asks Justices To Keep Gender-Affirming Care Ban
• Catching Up With Delaware's Chancery Court
• States Ask Justices To End Feds' Alleged Online Censorship
• 2 Defendants Cut Deal With DOJ In Houston Fraud Suit
• Proposed Class Action Settlement May Cost Acella $46.5M
• Calif. Hospital To Pay $2.1M After Prescription Overbilling
• 'No Surprises Act' Allows Fair Arbitration, Gov't Tells 5th Circ.
• Hospital Says Ohio Pot Law Doesn't Ax Employee Discipline
• JCPenney Cardholder's Proposed $5M Insurance Suit Fails
• Biotech Co. Hit With Investor Suit Over Alzheimer's Drug Trial
• Ozempic Injury Suits Consolidated In Eastern Pa. MDL
• Ga. Sues Federal Gov't Over Medicaid Expansion Program
• Biotech Co. Hits Ch. 11, Blames Drug Misfires, Criminal Case
• Potential Defendant Strategies Amid Calif. Privacy Questions
• CPAP Cleaner Co. Says Philips Can't Pin Recall On It
• Zymergen Ch. 11 Plan Confirmed After Investor Objection
• AHA Urges Justices To Review HHS Hospital Pay Formula
• Spinal Implant Maker Previews Ch. 11 Sale And Wind Down
• Crowell & Moring Int'l Names Former Merck Senior VP As CEO
• Healthcare Group Cano Health Hits Ch. 11 With $1.3B Debt
• Novo Holdings Buying Biopharma Co. Catalent In $16.5B Deal
• Health Net Loses Bid To Stop $65B Contract Award
• McKinsey's $78M Opioid Deal With Health Plans Hits Snag
• NYC Serves Up Final Rules For Permanent Outdoor Dining
• 3 Arguments, Hearings Benefits Attys Should Watch In Feb.
• 4th Circ. Vacates Va. Doctor's Conviction In Pill Mill Scheme
• Med Biller Who Posed As NBA Star, NFL Atty Gets 12 Years
• Pa. Panel Ditches Med. Mal. Suit Over Tardy Expert Report
• ABA Chides 5th Circ. At High Court Over Mifepristone Ruling
• Drugmaker Endo Wants To Extend Opioid Suit Pause
• ACLU Atty On How To Protect Civil Liberties In The AI Era
• Families New To Tylenol MDL Cite Expert To Avoid Dismissal
• Ill. COVID Wrongful Death Claims Can't Be Arbitrated
• Latham Led Firms In January IPOs As New Listings Pick Up
• Debt Collector Broke Billing Law Over 82K Times, Judge Says
• Ascension Says Medical Queries Don't Breach Genetic Privacy
• Pennsylvania AG's Clout In Opioid Deal Likely Has Wide Reach
• How Facilities Can Address Legal Risk Of Wandering Patients
• How Poor Governance, Weak Contracts Harm Cannabis Cos.
• Conn. Eye Patient Drops Bausch & Lomb Implant Claims
• Staffing Firm Challenges $9M Classification Ruling At 4th Circ.
• McCarter & English To Face Revised Biotech Malpractice Suit
• DLA Piper Hires McDermott's FDA Practice Leader In DC
• Morgan Lewis Accused Of Improperly Helping Health Biz CEO
• UPMC To Settle Tuberculosis Suit With $650 Payments
• Taxation With Representation: Simpson, Wachtell Lipton
• Del. Ruling Adds Momentum For Caremark Plaintiffs
• Calif. Pledges $2B In MoFo-Led COVID Education Settlement
• Wash. Hospitals Pay $158M To End Charity-Skimping Claims
• Ex-FDA Leaders Urge High Court To Nix Mifepristone Ruling
• 'Double Team' Argument No Reason To Sever Med Mal Claims
• Tenet Healthcare To Shed 4 Calif. Hospitals For $975M
• Warren Slams Prison Health Co.'s Revised Ch. 11 Plan
• FTC Puts Cap On Blackbaud's Data Retention In Breach Deal
• Pharma Hikma Reaches $150M Opioid Settlement With States
• Mich. Pays $13M Over Hospital's Surprise Active Shooter Drill
• Aetna Escapes Autism Benefits Denial Suit, For Now
• Denver Man Accused Of Romancing Women Into $121K Scam
• Bankrupt Pharma Co. Impel Gets OK For $17.5M Sale
• 5 Mass. Rulings You Might Have Missed In January
• Conn. Supreme Court Snapshot: Sleepy Juror, Surprise Billing
• Ga. Health System, Class Seek Initial OK Of $2M ERISA Deal
• NJ Says Constitution Doesn't Protect Medical Aid In Dying
• Ex-Nursing Head Drops Retaliation Suit Against Colo. Hospice
• Life Sciences VC Firm Seroba Closes $134M Fund
• Mich. High Court To Consider Lilly Insulin Pricing Probe
• State-Led Generic Drug Cases Removed From MDL
• How Biotech Cos. Can Utilize Synthetic Royalty Financing
• 2 SEC Orders Illuminate Bribery Risks For US-China Cos.
• Spinal Implant Maker Eyes Ch. 11 Wind-Down In Del.
• Pennsylvania Courts Settle DOJ Opioid Bias Claims For $100K
• Publicis Reaches $350M Opioid Settlement With All 50 States
• Cell Therapy Firm Kyverna Eyes $200M IPO As Pipeline Builds
• 3rd Circ. Backs NJ Town's Abortion Clinic Buffer Zones
• Colo. Judge Trims Travel Nurses' 'Bait And Switch' Suit
• The Legal Industry Needs A Cybersecurity Paradigm Shift
• 5th Circ. Orders La. Atty To Pay $29K For Frivolous Filings
• Best Practices For Untangling Mass Tort Claimants' Liens
• Fla. Nursing Home Mogul Reaches Plea Deal With Feds